Dear Sir/Madam, Pursuant to Code of Conduct to regulate, monitor and report Trading by Insider ("Code") and applicable SEBI Regulations, please find the attached intimation of closure ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prism Medico and Pharmacy Ltd has informed the BSE and MSEI that the trading window for dealing in the company's securities by insiders is closed from April 1, 2026. The window will reopen 48 hours after the company declares its financial results for the quarter and full financial year ending March 31, 2026. The intimation was signed by Director Davender Singh (DIN: 09447213) and filed under SEBI's Insider Trading Code of Conduct. No actual insider buy or sell transactions are reported in this filing — it is a standard pre-results compliance announcement.
This is a routine regulatory filing with no direct impact on the stock price. It signals that the company's Q4 and FY26 results are due soon, and reminds the market that company insiders are restricted from trading during this period.